SCHEMBL845002

SCHEMBL845002

COc1ccc(OC)c(C(=O)N2CCC[C@H]2C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4CCCN4C(=O)c4cc(OC)ccc4OC)cc3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
ALDH1A1 P00352 3/20 0.53
MAPK1 P28482 2/20 0.53
HTT P42858 1/20 0.53
TSHR P16473 1/20 0.53
EP300 Q09472 5/20 0.50
CREBBP Q92793 5/20 0.50
HCRTR1 O43613 1/20 0.50
HCRTR2 O43614 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 1/20 0.49
GFER P55789 1/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845539 0.97 HCRTR1 (0.54) CYP2C9CYP2C19SMN1; SMN2LMNAHPGD
SCHEMBL845290 0.92 HCRTR1 (0.52) CYP2C9CYP2C19SMN1; SMN2LMNAHPGD
SCHEMBL873577 0.91 LMNA (0.47) CYP2C9CYP2C19SMN1; SMN2LMNAHPGD
SCHEMBL845000 0.89 RHOC (0.51) CYP2C9CYP2C19SMN1; SMN2LMNAALDH1A1
SCHEMBL845284 0.87 MAPK1 (0.58) CYP2C9CYP2C19LMNAALDH1A1MAPK1
SCHEMBL845629 0.87 TSHR (0.50) SMN1; SMN2ALDH1A1MAPK1TSHREP300
SCHEMBL873856 0.84 HCRTR1 (0.45) CYP2C9CYP2C19SMN1; SMN2ALDH1A1MAPK1
SCHEMBL845157 0.83 ALDH1A1 (0.57) CYP2C9CYP2C19SMN1; SMN2LMNAHPGD
SCHEMBL845641 0.82 MAPK1 (0.53) CYP2C9CYP2C19LMNAALDH1A1MAPK1
SCHEMBL13272181 0.82 MAPK1 (0.53) CYP2C9CYP2C19LMNAALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed